Free Trial

Xometry (NASDAQ:XMTR) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Xometry logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • RBC raised its price target on Xometry from $100 to $117, while maintaining a “sector perform” rating; the new target implies about 1.55% upside from the stock’s quoted price.
  • Xometry’s latest quarter beat expectations, with earnings of $0.28 per share versus $0.19 forecast and revenue of $252.44 million, up 39.5% year over year.
  • Analysts’ consensus rating is “Moderate Buy,” with an average price target of $118.64. However, the company still reported a negative net margin and negative return on equity.
  • Interested in Xometry? Here are five stocks we like better.

Xometry (NASDAQ:XMTR - Get Free Report) had its price objective hoisted by Royal Bank Of Canada from $100.00 to $117.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a "sector perform" rating on the stock. Royal Bank Of Canada's target price would indicate a potential upside of 1.55% from the company's current price.

Other equities research analysts also recently issued research reports about the company. The Goldman Sachs Group increased their price objective on Xometry from $78.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, August 5th. Cantor Fitzgerald lifted their price objective on shares of Xometry from $110.00 to $114.00 and gave the company an "overweight" rating in a research report on Wednesday. Weiss Ratings restated a "sell (d-)" rating on shares of Xometry in a research note on Wednesday, August 26th. BNP Paribas Exane began coverage on shares of Xometry in a report on Friday, September 18th. They issued an "outperform" rating and a $120.00 target price on the stock. Finally, UBS Group raised their target price on shares of Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $118.64.

View Our Latest Stock Analysis on Xometry

Xometry Stock Up 3.5%

NASDAQ XMTR traded up $3.92 during trading hours on Wednesday, hitting $115.22. 317,210 shares of the company traded hands, compared to its average volume of 879,528. The business's 50-day moving average is $96.90 and its 200-day moving average is $76.46. Xometry has a twelve month low of $35.86 and a twelve month high of $117.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21. The stock has a market capitalization of $5.97 billion, a price-to-earnings ratio of -191.11 and a beta of 1.33.

Xometry (NASDAQ:XMTR - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.09. The firm had revenue of $252.44 million during the quarter, compared to the consensus estimate of $235.54 million. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%. The business's revenue was up 39.5% compared to the same quarter last year. During the same period last year, the company earned $0.11 earnings per share. Sell-side analysts anticipate that Xometry will post -0.01 earnings per share for the current year.

Insider Activity

In other news, CTO Vaidyanathan Raghavan sold 5,000 shares of the stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $96.77, for a total value of $483,850.00. Following the transaction, the chief technology officer directly owned 135,777 shares of the company's stock, valued at $13,139,140.29. This represents a 3.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Fabio Rosati sold 8,100 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $91.45, for a total transaction of $740,745.00. Following the completion of the transaction, the director directly owned 93,567 shares in the company, valued at $8,556,702.15. The trade was a 7.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 64,699 shares of company stock valued at $6,169,735. 9.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC lifted its holdings in shares of Xometry by 243.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 694,390 shares of the company's stock worth $29,015,000 after buying an additional 492,285 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Xometry by 26.9% in the second quarter. Wellington Management Group LLP now owns 1,322,581 shares of the company's stock valued at $127,656,000 after acquiring an additional 280,491 shares in the last quarter. Zevenbergen Capital Investments LLC grew its stake in shares of Xometry by 115.1% in the third quarter. Zevenbergen Capital Investments LLC now owns 297,552 shares of the company's stock valued at $30,603,000 after acquiring an additional 159,227 shares in the last quarter. Sylebra Capital LLC grew its stake in shares of Xometry by 31.3% in the first quarter. Sylebra Capital LLC now owns 535,624 shares of the company's stock valued at $21,875,000 after acquiring an additional 127,637 shares in the last quarter. Finally, Sei Investments Co. increased its position in Xometry by 45.6% during the first quarter. Sei Investments Co. now owns 274,641 shares of the company's stock worth $11,216,000 after acquiring an additional 85,989 shares during the period. Institutional investors and hedge funds own 97.31% of the company's stock.

Xometry News Summary

Here are the key news stories impacting Xometry this week:

  • Positive Sentiment: Q3 results beat expectations: Xometry reported earnings of $0.28 per share versus the $0.19 consensus, while revenue rose 40% year over year to a record $252 million, above the $235.54 million estimate. Xometry Reports Record Third Quarter 2026 Results
  • Positive Sentiment: Marketplace growth and customer expansion: Marketplace revenue increased 43% to $238 million, and active buyers grew 20% year over year to 93,812—evidence of continued demand and broader platform adoption. Xometry: 3 Key Takeaways for Long-Term Investors
  • Positive Sentiment: Analysts raised targets: Citizens JMP raised its target to $135 and maintained a Market Outperform rating; Rosenblatt lifted its target to $130 with a Buy rating; and Cantor Fitzgerald increased its target to $114 with an Overweight rating. Citizens raises Xometry price target
  • Negative Sentiment: Profitability remains a consideration: Despite the quarterly EPS beat, Xometry reported a negative net margin and negative return on equity, so investors may look for continued progress toward sustainable profitability.

Xometry Company Profile

(Get Free Report)

Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.

See Also

Analyst Recommendations for Xometry (NASDAQ:XMTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines